Pancreatic Cancer Research

ResearcherSapporo Medical UniversityActive in the last 2 years

Shoichiro Tange

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2126-6938; OpenAlex author ID A5039034876. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. Compressive stress inhibits proliferation in AsPC-1 pancreatic cancer cells and reduction of Myc protein. Co-author DOI 10.1371/journal.pone.0352769↗
  2. CLSPN Is Expressed in Pancreatic Cancer and Can Be a Target for Immunotherapy. Co-author DOI 10.21873/anticanres.18384↗
  3. MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 path… Co-author DOI 10.1186/s12885-022-10433-6↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fuko Miyake · 1 shared paper, 2026 · strength 0.36
  2. Hisashi Haga · 1 shared paper, 2026 · strength 0.36
  3. Atsushi Enomoto · 1 shared paper, 2026 · strength 0.36
  4. Hideharu Miura · 1 shared paper, 2026 · strength 0.24
  5. Yoshihiko Hirohashi · 1 shared paper, 2026 · strength 0.24
  6. Toshihiko Torigoe · 1 shared paper, 2026 · strength 0.24
  7. Takashi Tokino · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.